Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis: A Quasi-experimental Case-series Study - Scorecard - MDSpire

Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis: A Quasi-experimental Case-series Study

  • By

  • Nektaria Papadopoulou–Marketou

  • Anna Papageorgiou

  • Nikolaos Marketos

  • Panagiotis Tsiamyrtzis

  • Georgios Vavetsis

  • George P Chrousos

  • February 7, 2025

  • 0 min

Share

Clinical Scorecard: Short-duration, Low-impact, High-intensity Osteogenic Loading for Postmenopausal Osteoporosis: A Quasi-experimental Case Series Analysis

At a Glance

CategoryDetail
ConditionPostmenopausal osteoporosis characterized by reduced bone mineral density (BMD) and disrupted bone microarchitecture
Key MechanismsLow-impact, high-intensity osteogenic loading exercises (Osteostrong® system) aiming to improve BMD and trabecular bone score (TBS)
Target PopulationPeri- and postmenopausal women with osteoporosis
Care SettingOutpatient clinical setting with weekly 10-minute exercise sessions

Key Highlights

  • Osteostrong® intervention involves brief (10-minute), weekly, low-impact, high-intensity osteogenic loading exercises using four devices.
  • Significant lumbar spine BMD improvements observed in women receiving Osteostrong® combined with antiresorptive medication over 12 months.
  • TBS and femoral neck BMD changes were not significantly improved after adjustment, indicating modest effects and need for further randomized trials.

Guideline-Based Recommendations

Diagnosis

  • Use dual-energy x-ray absorptiometry (DXA) to measure BMD at lumbar spine, total hip, and femoral neck.
  • Incorporate trabecular bone score (TBS) from lumbar spine DXA images to assess bone microarchitecture and fracture risk.
  • Diagnose osteoporosis with T-score ≤ -2.5 at femoral neck, lumbar spine, or total hip, using the lowest T-score from femoral neck or total hip.

Management

  • Pharmacotherapy remains standard, but nonpharmaceutical methods such as calcium and vitamin D supplementation and exercise are recommended for prevention.
  • Osteogenic loading exercises like Osteostrong® may provide modest lumbar spine BMD improvements, especially when combined with antiresorptive medication.
  • Exercise parameters for osteoporosis prevention are not yet standardized; low-impact, high-intensity loading is a promising approach.

Monitoring & Follow-up

  • Assess changes in BMD and TBS at baseline and after 12 months to evaluate treatment effects.
  • Consider multiple anatomical sites (lumbar spine, total hip, femoral neck) due to regional BMD discordances affecting fracture risk assessment.

Risks

  • Low-impact osteogenic loading exercises are generally safe but require further study to confirm efficacy and safety.
  • Measurement errors and osteoarthritic changes can affect BMD readings, particularly at the femoral neck.

Patient & Prescribing Data

Peri- and postmenopausal women with osteoporosis, including those on antiresorptive medication

Osteostrong® combined with antiresorptive therapy showed significant lumbar spine and some hip BMD improvements over 12 months; effects without medication or on TBS were less clear.

Clinical Best Practices

  • Use DXA scans at lumbar spine, total hip, and femoral neck for comprehensive osteoporosis diagnosis and monitoring.
  • Incorporate TBS measurements to better assess bone microarchitecture and fracture risk.
  • Recommend calcium and vitamin D supplementation alongside pharmacotherapy and consider adding structured osteogenic loading exercises.
  • Monitor BMD changes at multiple sites to capture regional differences and improve fracture risk prediction.
  • Educate patients on the potential benefits and limitations of nonpharmacologic interventions like Osteostrong®.

References

Original Source(s)

Related Content